Palatin Technologies (PTN) Set to Announce Earnings on Friday

Palatin Technologies (NYSEAMERICAN:PTN) will likely be issuing its Q1 2027 results before the market opens on Friday, November 13th. Analysts expect the company to announce earnings of ($0.3867) per share and revenue of $2.98 million for the quarter. Parties can check the company’s upcoming Q1 2027 earnings summary page for the latest details on the call scheduled for Thursday, November 19, 2026 at 11:00 AM ET.

Palatin Technologies (NYSEAMERICAN:PTN) last released its earnings results on Monday, September 28th. The company reported ($1.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.20) by $0.09. The business had revenue of $0.30 million during the quarter, compared to the consensus estimate of $1.50 million.

Palatin Technologies Price Performance

Shares of NYSEAMERICAN:PTN opened at $6.89 on Wednesday. The company’s 50-day moving average price is $8.56 and its two-hundred day moving average price is $13.64. Palatin Technologies has a one year low of $4.51 and a one year high of $31.00.

Palatin Technologies Company Profile

Palatin Technologies, Inc. is a biopharmaceutical company focused on developing medicines that target melanocortin receptors, a group of receptors involved in regulating inflammation, immune responses, metabolism and sexual function. The company’s research programs are designed to address conditions for which targeted therapies may offer an alternative to existing treatments. Palatin’s most recognized product is Vyleesi (bremelanotide), a melanocortin receptor agonist approved by the U.S. Food and Drug Administration for the treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women.